These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 848221

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Delayed secondary immune response in mice immunized with Toxoplasma antigens and its effect for protection against Toxoplasma gondii.
    Yano K, Nakabayashi T.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):381-9. PubMed ID: 6730784
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Immunological processes in the course of the Toxoplasma gondii infection].
    Sroka J, Karamon J, Cencek T.
    Wiad Parazytol; 2009 Mar; 55(2):141-6. PubMed ID: 19670529
    [Abstract] [Full Text] [Related]

  • 26. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
    Chen G, Chen H, Guo H, Zheng H.
    Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR, Meng XL, Ma GY, Ma XM.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
    [Abstract] [Full Text] [Related]

  • 30. [Some aspects of immune response in toxoplasmosis].
    Dziubek Z, Zarnowska H, Basiak W, Górski A, Kajfasz P.
    Przegl Epidemiol; 2001 Aug; 55(4):495-502. PubMed ID: 11921737
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis.
    Derouin F, Rabian-Herzog C, Sulahian A.
    J Clin Lab Immunol; 1989 Oct; 30(2):97-102. PubMed ID: 2641536
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Selective concurrent suppression of the process of rosette-forming cell accumulation during the immune response].
    Simonian SA, Khorobrykh VV, Iurin BL, Golovanova TA, Kul'bert AI.
    Biull Eksp Biol Med; 1976 Jun; 81(6):715-7. PubMed ID: 1085182
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Protection against lethal toxoplasmosis in mice by an avirulent strain of Toxoplasma gondii: stimulation of IFN-gamma and TNF-alpha response.
    Haque S, Franck J, Dumon H, Kasper LH, Haque A.
    Exp Parasitol; 1999 Dec; 93(4):231-40. PubMed ID: 10600449
    [Abstract] [Full Text] [Related]

  • 39. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR, McLeod R, Mack D, Smith J, Khan IA, Ely KH, Kasper LH.
    J Immunol; 1993 May 01; 150(9):3951-64. PubMed ID: 7682587
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.